Second primary malignancy following multiple myeloma (MM) was reported several years ago. There are also rare reports of cases with synchronous MM and other malignancies. To our knowledge, only one case of MM following bladder cancer has been reported in the literature. Here, we report the second case occurred three months after diagnosis of bladder cancer.

usual gynecologic malignancy that accounts for less than 1% of all malignancies of the female genitalia (1). Among them, papillary serous adenocarcinoma appears to be the most common histologic type (2). Endometrial cancer is one of the common gynecologic malignancies. Most endometrial cancers are endometrioid adenocarcinomas and only approximately 10% are uterine papillary serous carcinomas (3...

We describe a rare case of paraneoplastic cerebellar degeneration (with detectable antineuronal antibody anti-Yo) in which (18)F-FDG PET/CT aided in the detection of 2 synchronous malignancies (one thyroid cancer and the other breast cancer). Interestingly, the primary breast malignancy was non-(18)F-FDG-avid and was detected through the presence of a metastatic (18)F-FDG-avid axillary lymph no...

BACKGROUND The hybrid method 18F-FDG PET/ CT has been proven as a method of choice in oncology for diagnostics, staging, restaging of the tumor and evaluation of the therapeutic effect. The aim of the study was to determine the value of 18F-FDG PET/ CT for detection of synchronous tumors and consequently the influence on the patients management. MATERIAL AND METHODS The examinations were perf...

The simultaneous (synchronous) detection of 3 primary tumors is rare in clinical practice. Recognizing and differentiating metastatic malignancies have always been challenging for clinicians pathologists; however, treatment outcomes prognoses highly depend on this recognition. Here, we used immunostaining a new approach that, to our knowledge, few people know about based an understanding exosom...

background: patients which have diagnosed with a cancer, have a life time risk for developing another de novo malignancy depending on various inherited, environmental and iatrogenic risk factors. cancer victims could survive longer due to settling treatment modalities, and then would likely develop a new metachronous malignancy. this article aims to report our observed trend of increasing, in p...